Trials / Completed
CompletedNCT04293029
Pharmacokinetics and Safety of SHR0302 in Patients With Hepatic Impairment
Pharmacokinetics and Safety of SHR0302 in Patients With Mild, Moderate Hepatic Impairment and Normal Liver Function in Phase I Clinical Study
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 24 (actual)
- Sponsor
- Jiangsu HengRui Medicine Co., Ltd. · Industry
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
Study to Evaluate Pharmacokinetics and Safety of SHR0302 in Patients With Mild, Moderate Hepatic Impairment and Normal Liver Function in Phase I Clinical Study
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | SHR0302 | SHR0302 |
Timeline
- Start date
- 2020-05-20
- Primary completion
- 2020-12-27
- Completion
- 2020-12-30
- First posted
- 2020-03-03
- Last updated
- 2021-10-14
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT04293029. Inclusion in this directory is not an endorsement.